日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/06/30 | 5,980 | 5,980 | 5,872 | 5,874 | -178 | -2.9% | 509,000 |
| 2023/06/29 | 6,079 | 6,119 | 5,994 | 6,052 | -2 | ±0% | 434,200 |
| 2023/06/28 | 6,024 | 6,069 | 5,980 | 6,054 | +25 | +0.4% | 433,100 |
| 2023/06/27 | 6,149 | 6,149 | 5,977 | 6,029 | -179 | -2.9% | 541,700 |
| 2023/06/26 | 6,200 | 6,218 | 6,070 | 6,208 | ±0 | ±0% | 375,000 |
| 2023/06/23 | 6,369 | 6,380 | 6,200 | 6,208 | -109 | -1.7% | 376,800 |
| 2023/06/22 | 6,375 | 6,427 | 6,310 | 6,317 | -107 | -1.7% | 307,200 |
| 2023/06/21 | 6,479 | 6,548 | 6,420 | 6,424 | -3 | ±0% | 358,100 |
| 2023/06/20 | 6,452 | 6,470 | 6,394 | 6,427 | -57 | -0.9% | 211,500 |
| 2023/06/19 | 6,539 | 6,592 | 6,453 | 6,484 | +17 | +0.3% | 275,700 |
| 2023/06/16 | 6,373 | 6,514 | 6,361 | 6,467 | +89 | +1.4% | 504,000 |
| 2023/06/15 | 6,455 | 6,505 | 6,378 | 6,378 | -125 | -1.9% | 287,200 |
| 2023/06/14 | 6,547 | 6,586 | 6,450 | 6,503 | -37 | -0.6% | 344,400 |
| 2023/06/13 | 6,597 | 6,683 | 6,516 | 6,540 | -21 | -0.3% | 436,200 |
| 2023/06/12 | 6,516 | 6,672 | 6,513 | 6,561 | +77 | +1.2% | 256,000 |
| 2023/06/09 | 6,516 | 6,546 | 6,453 | 6,484 | +68 | +1.1% | 257,600 |
| 2023/06/08 | 6,561 | 6,574 | 6,387 | 6,416 | -124 | -1.9% | 228,500 |
| 2023/06/07 | 6,676 | 6,694 | 6,513 | 6,540 | -69 | -1% | 275,500 |
| 2023/06/06 | 6,515 | 6,625 | 6,482 | 6,609 | +53 | +0.8% | 224,400 |
| 2023/06/05 | 6,615 | 6,624 | 6,501 | 6,556 | +6 | +0.1% | 371,500 |
| 2023/06/02 | 6,500 | 6,600 | 6,450 | 6,550 | +140 | +2.2% | 281,100 |
| 2023/06/01 | 6,450 | 6,470 | 6,380 | 6,410 | +30 | +0.5% | 214,200 |
| 2023/05/31 | 6,290 | 6,440 | 6,280 | 6,380 | ±0 | ±0% | 584,400 |
| 2023/05/30 | 6,420 | 6,510 | 6,320 | 6,380 | -40 | -0.6% | 178,600 |
| 2023/05/29 | 6,500 | 6,510 | 6,390 | 6,420 | -20 | -0.3% | 207,600 |
| 2023/05/26 | 6,470 | 6,500 | 6,410 | 6,440 | -100 | -1.5% | 239,700 |
| 2023/05/25 | 6,600 | 6,710 | 6,540 | 6,540 | +90 | +1.4% | 387,800 |
| 2023/05/24 | 6,530 | 6,540 | 6,450 | 6,450 | -60 | -0.9% | 236,700 |
| 2023/05/23 | 6,550 | 6,580 | 6,480 | 6,510 | +80 | +1.2% | 231,700 |
| 2023/05/22 | 6,460 | 6,480 | 6,380 | 6,430 | +20 | +0.3% | 166,200 |
| 2023/05/19 | 6,350 | 6,430 | 6,320 | 6,410 | +60 | +0.9% | 258,400 |
| 2023/05/18 | 6,430 | 6,450 | 6,300 | 6,350 | -10 | -0.2% | 260,400 |
| 2023/05/17 | 6,400 | 6,440 | 6,350 | 6,360 | -40 | -0.6% | 276,900 |
| 2023/05/16 | 6,210 | 6,400 | 6,170 | 6,400 | +200 | +3.2% | 402,100 |
| 2023/05/15 | 6,160 | 6,210 | 6,150 | 6,200 | -10 | -0.2% | 257,300 |
| 2023/05/12 | 6,200 | 6,280 | 6,070 | 6,210 | +50 | +0.8% | 396,300 |
| 2023/05/11 | 6,160 | 6,210 | 6,150 | 6,160 | -60 | -1% | 171,200 |
| 2023/05/10 | 6,280 | 6,290 | 6,200 | 6,220 | -70 | -1.1% | 169,700 |
| 2023/05/09 | 6,240 | 6,310 | 6,230 | 6,290 | +60 | +1% | 184,900 |
| 2023/05/08 | 6,290 | 6,290 | 6,190 | 6,230 | ±0 | ±0% | 204,500 |
| 2023/05/02 | 6,300 | 6,320 | 6,190 | 6,230 | -40 | -0.6% | 148,500 |
| 2023/05/01 | 6,260 | 6,290 | 6,220 | 6,270 | +70 | +1.1% | 199,800 |
| 2023/04/28 | 6,190 | 6,260 | 6,180 | 6,200 | +70 | +1.1% | 205,800 |
| 2023/04/27 | 6,090 | 6,140 | 6,060 | 6,130 | -10 | -0.2% | 157,800 |
| 2023/04/26 | 6,200 | 6,270 | 6,120 | 6,140 | -100 | -1.6% | 280,700 |
| 2023/04/25 | 6,180 | 6,290 | 6,140 | 6,240 | +60 | +1% | 271,300 |
| 2023/04/24 | 6,220 | 6,240 | 6,160 | 6,180 | -10 | -0.2% | 245,500 |
| 2023/04/21 | 6,070 | 6,250 | 6,040 | 6,190 | +120 | +2% | 342,100 |
| 2023/04/20 | 6,230 | 6,230 | 6,010 | 6,070 | +20 | +0.3% | 353,800 |
| 2023/04/19 | 6,020 | 6,110 | 5,980 | 6,050 | -70 | -1.1% | 273,000 |
451～
500
件表示中 / 3693件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 349,300円 | +7.9% | +8.9% | 3.55% | 7.47倍 | 1.00倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ツムラ | 427,100円 | +20.9% | +87.3% | 3.18% | 9.53倍 | 1.10倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| ペプチド | 189,200円 | +5.0% | +1.5% | 0.00% | 16.24倍 | 4.32倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サワイＧＨＤ | 200,100円 | +4.0% | +25.4% | 2.65% | 8.75倍 | 1.15倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| 科研薬 | 401,800円 | +30.5% | +111.0% | 4.73% | 11.33倍 | 0.98倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム
